Salivary Biomarkers for Oral Cancer Detection: An Exploratory Systematic Review
- PMID: 38473882
- PMCID: PMC10932009
- DOI: 10.3390/ijms25052634
Salivary Biomarkers for Oral Cancer Detection: An Exploratory Systematic Review
Abstract
Different efforts have been made to find better and less invasive methods for the diagnosis and prediction of oral cancer, such as the study of saliva as a source of biomarkers. The aim of this study was to perform a scoping review about salivary molecules that have been assessed as possible biomarkers for the diagnosis of oral squamous cell carcinoma (OSCC). A search was conducted using EBSCO, PubMed (MEDLINE), Scopus, and Web of Science. The research question was as follows: which molecules present in saliva have utility to be used as biomarkers for the early detection of oral cancer? Sixty-two studies were included. Over 100 molecules were assessed. Most of the markers were oriented towards the early diagnosis of OSCC and were classified based on their ability for detecting OSCC and oral potentially malignant disorders (OPMDs), OSCC outcome prediction, and the prediction of the malignant transformation of OPMDs. TNF-α, IL-1β, IL-6 IL-8, LDH, and MMP-9 were the most studied, with almost all studies reporting high sensitivity and specificity values. TNF-α, IL-1β, IL-6 IL-8, LDH, and MMP-9 are the most promising salivary biomarkers. However, more studies with larger cohorts are needed before translating the use of these biomarkers to clinical settings.
Keywords: biomarkers; mouth neoplasm; oral cancer; oral potentially malignant disorder; saliva.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Role of selected salivary inflammatory cytokines in the diagnosis and prognosis of oral squamous cell carcinoma. A Systematic Review and Meta-analysis.Med Oral Patol Oral Cir Bucal. 2023 Sep 1;28(5):e474-e486. doi: 10.4317/medoral.25889. Med Oral Patol Oral Cir Bucal. 2023. PMID: 37099710 Free PMC article.
-
Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.Asian Pac J Cancer Prev. 2014;15(17):7141-8. doi: 10.7314/apjcp.2014.15.17.7141. Asian Pac J Cancer Prev. 2014. PMID: 25227804
-
Validation of Salivary Markers, IL-1β, IL-8 and Lgals3bp for Detection of Oral Squamous Cell Carcinoma in an Indian Population.Sci Rep. 2020 Apr 30;10(1):7365. doi: 10.1038/s41598-020-64494-3. Sci Rep. 2020. PMID: 32355279 Free PMC article.
-
Could salivary biomarkers be useful in the early detection of oral cancer and oral potentially malignant disorders, and is there a relationship between these biomarkers and risk factors?Evid Based Dent. 2022 Mar;23(1):30-31. doi: 10.1038/s41432-022-0249-8. Epub 2022 Mar 25. Evid Based Dent. 2022. PMID: 35338326
-
Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors - A systematic review.Expert Rev Mol Diagn. 2021 Aug;21(8):789-807. doi: 10.1080/14737159.2021.1944106. Epub 2021 Jul 12. Expert Rev Mol Diagn. 2021. PMID: 34148471
Cited by
-
Saliva in Balancing Oral and Systemic Health, Oral Cancer, and Beyond: A Narrative Review.Cancers (Basel). 2024 Dec 23;16(24):4276. doi: 10.3390/cancers16244276. Cancers (Basel). 2024. PMID: 39766175 Free PMC article. Review.
-
Oral and Gingival Crevicular Fluid Biomarkers for Jawbone Turnover Diseases: A Scoping Review.Diagnostics (Basel). 2024 Sep 30;14(19):2184. doi: 10.3390/diagnostics14192184. Diagnostics (Basel). 2024. PMID: 39410587 Free PMC article.
-
A new perspective on diagnostic strategies concerning the potential of saliva-based miRNA signatures in oral cancer.Diagn Pathol. 2024 Nov 16;19(1):147. doi: 10.1186/s13000-024-01575-1. Diagn Pathol. 2024. PMID: 39548527 Free PMC article. Review.
-
Emerging salivary biomarkers for early detection of oral squamous cell carcinoma.World J Clin Oncol. 2025 Apr 24;16(4):103803. doi: 10.5306/wjco.v16.i4.103803. World J Clin Oncol. 2025. PMID: 40290680 Free PMC article. Review.
-
Early Molecular Diagnosis and Comprehensive Treatment of Oral Cancer.Curr Issues Mol Biol. 2025 Jun 12;47(6):452. doi: 10.3390/cimb47060452. Curr Issues Mol Biol. 2025. PMID: 40699851 Free PMC article. Review.
References
-
- Gualtero D.F., Suarez Castillo A. Acta Odontologica Scandinavica. Taylor and Francis Ltd.; Abingdon, UK: 2016. Biomarkers in saliva for the detection of oral squamous cell carcinoma and their potential use for early diagnosis: A systematic review; pp. 170–177. - PubMed
-
- Warnakulasuriya S., Kujan O., Aguirre-Urizar J.M., Bagan J.V., González-Moles M., Kerr A.R., Lodi G., Mello F.W., Monteiro L., Ogden G.R., et al. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021;27:1862–1880. doi: 10.1111/odi.13704. - DOI - PubMed
-
- Iocca O., Sollecito T.P., Alawi F., Weinstein G.S., Newman J.G., De Virgilio A., Di Maio P., Spriano G., Pardiñas López S., Shanti R.M. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck. 2020;42:539–555. doi: 10.1002/hed.26006. - DOI - PubMed
-
- Al-Maweri S.A., Halboub E., Al-Qadhi G., Al-Wesabi M., Al-Sharani H.M., Parveen S., Alhashimi N., Almeslet A., Alhajj M.N. Efficacy of lycopene for management of oral potentially malignant disorders: A systematic review and meta-analysis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2023;135:79–95. doi: 10.1016/j.oooo.2022.08.004. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous